Workflow
Moderna(MRNA) - 2024 Q4 - Annual Results
MRNAModerna(MRNA)2025-02-14 11:30

Financial Performance - Moderna, Inc. generated 3.0−3.1billioninproductsalesforthefiscalyearendedDecember31,2024[4]CashandInvestments−Thecompany′scash,cashequivalents,andinvestmentsinmarketablesecuritiesareapproximately3.0-3.1 billion in product sales for the fiscal year ended December 31, 2024[4] Cash and Investments - The company's cash, cash equivalents, and investments in marketable securities are approximately 9.5 billion as of December 31, 2024[4] Audit Status - The financial information provided is preliminary and unaudited, with ongoing audits that may result in changes[5]